APAC Cell & Gene Therapy Center

Bring new cell and gene therapies to market faster.

The growth of cell and gene therapies signals disruption for the entire healthcare ecosystem, requiring new thinking around development, administration, value, and reimbursement. IQVIA can help you develop and commercialize your therapy, and get ready for what's next. 

End-to-End Cell and Gene Therapy Expertise

IQVIA brings together exceptional expertise in Cell and Gene Therapy (CAGT) across the Cell and Gene Therapy development lifecycle, to help you increase the efficiency of your program and maximize the value of new therapies.

  • Integrated CAGT Solutions to power your CAGT development program and bring new therapies to patients, faster
  • CAGT Consulting Solutions to provide you with market insights, translational science support, regulatory and clinical strategies
  • Connected Intelligence to overcome trial challenges by bringing together scientific and therapeutic expertise, technology, and real-world health care data to inform decisions across the CAGT development lifecycle
  • Meticulous Logistics Management with protocol specific process mapping and logistics workflow, leaving nothing to chance.
cell and gene therapy

IQVIA’s Cell and Gene Therapy Center of Excellence

IQVIA established the Cell and Gene Therapy Center of Excellence in 2019 to develop patient-centered, data driven, hand-tailored strategies for CAGT trials. With the ultimate goal of getting new treatments to patients faster.

Leveraging in-depth therapeutic expertise and operational leadership, IQVIA is prepared to be your CRO partner - providing end-to-end expertise and services, tailored to the needs of CAGT drug development.

Medical professionals observing demonstration

View Regional Sites

If you are interested, learn more about our regional Cell and Gene Therapy centers of excellence in these country locations:

Contact Us